- 首頁
- App 分析
- AnticoagEvaluator
- AnticoagEvaluator Vs. MAQI2 Anticoagulation Toolkit
AnticoagEvaluator 與 MAQI2 Anticoagulation Toolkit 使用情況與統計
Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for antithrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com
- Apple App Store
- 免費版
- 醫療
商店排名
- -
This mobile app provides healthcare practitioners with an up-to-date, easy-to-use resource for managing anticoagulation patients more safely and effectively. The content was developed by the Michigan Anticoagulation Quality Improvement Initiative (MAQI2), a Blue Cross Blue Shield/Blue Care Network of Michigan sponsored consortium of anticoagulation clinics and experts from across the state of Michigan, and is based on the latest guidelines and research.
- Apple App Store
- 免費版
- 醫療
商店排名
- -
AnticoagEvaluator與 MAQI2 Anticoagulation Toolkit 比較排名
比較過去 28 天的 AnticoagEvaluator 排名趨勢與 MAQI2 Anticoagulation Toolkit
排名
無可用數據
各國 AnticoagEvaluator vs. MAQI2 Anticoagulation Toolkit 排名比較
比較過去 28 天的 AnticoagEvaluator 排名趨勢與 MAQI2 Anticoagulation Toolkit
無可顯示數據
使用我們的免費試用版,與所有網站進行比較
AnticoagEvaluator VS.
MAQI2 Anticoagulation Toolkit
12月 19, 2024